CLARITAS PHARMACEUTICALS INC (CLAS.CA) Stock Income Statement
TSX-V:CLAS - TSX Venture Exchange - CA1806342061 - Common Stock - Currency: CAD
| TTM (2021-9-30) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | -713.00K | -12.35M | -7.89M | 4.47M | 4.92M | |||
| Research and Development | N/A | -2.06M | 5.79M | 7.75M | 1.67M | |||
| Selling, General, and Administrative Expenses | 1.57M | 1.87M | 3.66M | 3.24M | 3.24M | |||
| Operating Income | 713.00K | 12.35M | 7.89M | -4.47M | -4.92M | |||
| Interest Income/Expense | -104.00K | 2.65M | 268.00K | 14.01M | -9.11M | |||
| Other Income/Expense | N/A | -45.00K | -46.00K | -2.58M | -17.84M | |||
| Non Recurring Items | N/A | -15.63M | -33.95M | -113.00K | 0.00 | |||
| Income Before Taxes | -1.86M | -674.00K | -25.83M | 6.84M | -31.86M | |||
| Income Tax | 56.00K | -4.88M | -4.62M | -99.00K | 0.00 | |||
| Net Income | -4.72M | 4.21M | -21.21M | 6.93M | -31.86M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.15 | 0.16 | -0.95 | 0.64 | -5.13 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in USD